to on-going challenges, the Company has promptly adjusted its marketing strategy and promotion, focusing more on the domestic markets to lessen the impacts of the situation. In 2020, the Company has

and 8.87 satang/KWh in September 2017. This enables us to increase our selling price to IU from 3.13 Baht/KWh for Q2’2017 to 3.18 Baht/KWh for Q3’2017 because our price is adjusted by reference to the

sales to EGAT increased 6.2% y-on-y and 3.5% q-on-q (3.07 Baht/KWh in 2018 / 3.24 Baht/KWh in Q4’2018) because the energy payment is generally adjusted to reflect changes in natural gas price which rose

period.  Electricity price sales to EGAT increased 1.7% y-on-y and 4.5% q-on-q (2.94 Baht/KWh in 6M’2018 / 3.01 Baht/KWh in Q2’2018) because the energy payment is generally adjusted to reflect changes in

sales to EGAT increased 3.4% y-on-y and 3.0% q-on-q (3.00 Baht/KWh in 9M’2018 / 3.10 Baht/KWh in Q3’2018) because the energy payment is generally adjusted to reflect changes in natural gas price

gains/losses wherein inventory gains decrease the cost of sales and inventory losses increase the cost of sales. Core Net Profit is the Reported Net Profit less extraordinary items less tax adjusted

Company Limited as of 31st December 2019 as follows: A. Book value B. Adjusted book value based on market value C. Discounted cash flow method Value of shares of Modern Pharma Company Limited based on

รวมค่ำตัด จ ำหน่ำย (Adjusted Net Income)3 1,441 1,948 2,264 57% 16% 2,383 4,212 77% อัตรำก ำไรขัน้ต้น (%) 30% 29% 31% 1% 2% 29% 30% 1% อัตรำก ำไรสุทธิ (%) 5% 9% 10% 5% 2% 7% 11% 4% Adjusted Net Income

will be adjusted to increase or decrease from cash or cash equivalent, account receivebles and other receivables, other current assets minus the account payables and other payables, current liabilities

บริษัทใหญ่ ท่ีไม่รวมค่ำตัด จ ำหน่ำย (Adjusted Net Income)3 1,265 2,264 2,937 132% 30% 3,648 7,149 96% อัตรำก ำไรขัน้ต้น (%) 28% 31% 32% 4% 1% 29% 31% 2% อัตรำก ำไรสุทธิ (%) 5% 10% 16% 11% 5% 6% 13% 7